Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT02256982. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma
ClinicalTrials.gov study NCT00859469. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma
ClinicalTrials.gov study NCT02527772. IPD Sharing: Not stated. Countries: 0. Publications: 2.
A Study of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 in Participants With Locally Advanced, Unresectable Pancreatic Cancer
ClinicalTrials.gov study NCT02210559. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing Cystectomy
ClinicalTrials.gov study NCT03294304. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic Cancer
ClinicalTrials.gov study NCT00577889. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary Cancer
ClinicalTrials.gov study NCT00447122. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE)
ClinicalTrials.gov study NCT02436668. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Necitumumab in the Neoadjuvant Setting With Gemcitabine in Surgically Resectable - 14X-US-I001
ClinicalTrials.gov study NCT03574818. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
ClinicalTrials.gov study NCT01395017. IPD Sharing: Not stated. Countries: 15. Publications: 0.
Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)
ClinicalTrials.gov study NCT01418001. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated, Unresectable, Locally Adv
ClinicalTrials.gov study NCT03267940. IPD Sharing: NO. Countries: 3. Publications: 0.
The ASCEND Study: Gemcitabine and Nab-Paclitaxel With LSTA1 (Certepetide) or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma
ClinicalTrials.gov study NCT05042128. IPD Sharing: NO. Countries: 2. Publications: 0.
A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov study NCT00096993. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy
ClinicalTrials.gov study NCT00919061. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Gemcitabine Submucosal Injection for Preventing Recurrence in Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Randomized Trial
ClinicalTrials.gov study NCT07198451. IPD Sharing: YES. Countries: 0. Publications: 12.
Neoadjuvant Gemcitabine and Fractionated, Weekly Cisplatin For Muscle Invasive Bladder Cancer and Patients Not Candidates For High Dose Cisplatin
ClinicalTrials.gov study NCT02030574. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer
ClinicalTrials.gov study NCT00114218. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or Gemcitabine
ClinicalTrials.gov study NCT03714555. IPD Sharing: NO. Countries: 1. Publications: 0.
Sorafenib, Gemcitabine, and Capecitabine in Treating Patients With Unresectable and/or Metastatic Kidney Cancer
ClinicalTrials.gov study NCT00121251. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.